Momenta Pharmaceuticals Stock News

Getting in on the extensive merger and acquisition game of large pharmaceutical companies is the ultimate endgame for Exelixis, a biotech that already boasts an established cancer-focused product line

We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors

Halvorsen's 13F portfolio value increased from $19.21B to $23.14B. The number of positions increased from 64 to 71.

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.

Low interest rates and suburban refuges from Covid-19 are driving housing starts. Some indirect beneficiaries: the home-improvement chains. But how long will the boom last?

J&J is seizing on cheap pandemic funding available in the booming U.S. corporate bond market to raise enough money to pay for its acquisition of Momenta, and...

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) 10X Genomics Inc (NASDAQ: TXG) ALX Oncology Holdings Inc (NASDAQ: ALXO) Avenue Therapeutics Inc (NASDAQ: ATXI)...

BALA CYNWYD, PA / ACCESSWIRE / August 19, 2020 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Momenta Pharmaceuticals, Inc.

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Momenta Pharmaceuticals, Inc. ("MNTA" or the "Company") (NASDAQ: MNTA) in con

NEW YORK, NY / ACCESSWIRE / August 19, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating:Analog Devices, Inc.

U.S. stocks finished lower Wednesday, a day after the S&P 500 index scored its first record close in six months, while the minutes of the Federal Reserve’s...

The Nasdaq Composite (NASDAQINDEX: ^IXIC) has been at record levels, but a late afternoon decline prevented the index from hitting a third straight all-time high. The Federal Reserve's release of min

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Momenta Pharmaceut

Shares of Momenta Pharmaceuticals (NASDAQ: MNTA) soared on Wednesday after the biotechnology company announced it had agreed to be acquired by Johnson & Johnson (NYSE: JNJ). As of 1:40 p.m. EDT, Mom